ACT for Methamphetamine Use Disorder in Women and Gender Non-Conforming Individuals

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

April 1, 2025

Conditions
Methamphetamine AbuseMethamphetamine-dependence
Interventions
BEHAVIORAL

Acceptance Commitment Therapy

"ACT: Consists of 15 sessions, twice per week. Each session is approximately 2.5 hours including breaks. Clients cover 3 modules (OPEN, ACTIVE, AWARE). Any participant who requires access to a device for any part of the study will be provided with one for the duration of the study.~CM: Participants will be given progressive compensation for session attendance via gift cards or e-gift cards amounting to $520.~Motivation Building Session: The study clinician will meet with each of the participants to explain the process of the therapy, reinforce expectations, and address any concerns or hesitations, and build motivation and commitment to fully engage in the program.~ChillTime App Participants rate their emotional state and choose a coping strategy (either physical, emotional, cognitive or spiritual). The app's algorithm learns the individual's strategy preferences over time, allowing for more personalized suggestions. Participants are also able to access coping strategies ad hoc."

Trial Locations (1)

M5B 2K3

Centre for Addiction and Mental Health, Toronto

All Listed Sponsors
lead

Centre for Addiction and Mental Health

OTHER

NCT05334914 - ACT for Methamphetamine Use Disorder in Women and Gender Non-Conforming Individuals | Biotech Hunter | Biotech Hunter